Skip to main content

Cepheid’s Shares Rise 15 Percent

Shares of Cepheid rose 15 percent for the five-day trading period ended Tuesday. The stock led the 18 firms that gained ground during a strong week for the BCW Index and the stock market in general.
 
Illumina’s shares rose 9.7 percent, Qiagen’s rose 9 percent, and Affymetrix’s shares climbed 8.8 percent for the week.
 
Only three firms posted declines for the week, with Sequenom’s stock falling the most at 4.3 percent.
 

Overall, the Index was up 2.6 percent for the week, matching the gains for the Dow Jones Industrial Average. The Nasdaq rose 3 percent, and the Nasdaq Biotech Index closed up 2 percent for the tracking period.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(June 19, 2007)
Starting Price
(
June 12, 2007)
% change
Affymetrix
AFFX
26.85
24.69
8.75
Agilent
A
39.31
37.47
4.91
Applied Biosystems
ABI
28.70
28.48
0.77
Beckman
BEC
66.76
67.16
-0.60
Becton Dickinson
BDX
75.34
74.44
1.21
Bio-Rad
BIO
74.04
73.68
0.49
Bruker
BRKR
9.24
9.15
0.98
Caliper
CALP
4.39
4.21
4.28
Cepheid
CPHD
13.06
11.36
14.96
Illumina
ILMN
40.54
36.96
9.69
Invitrogen
IVGN
73.96
73.82
0.19
Luminex
LMNX
12.56
11.92
5.37
MDS
MDZ
20.48
19.72
3.85
Millipore
MIL
77.30
74.44
3.84
PerkinElmer
PKI
26.66
26.36
1.14
Qiagen
QGEN
18.14
16.65
8.95
Sequenom
SQNM
4.50
4.70
-4.26
Sigma-Aldrich
SIAL
42.49
41.12
3.33
Thermo
TMO
53.40
51.44
3.81
Third Wave
TWTI
5.42
5.54
-2.17
Waters
WAT
60.44
60.53
-0.15
BCW Index Average
36.84
35.90
2.62
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.